Rishi Goel

Ustekinumab versus adalimumab for induction and maintenance therapy in biologic-naive patients with moderately to severely active Crohn's disease: a multicentre, randomised, double-blind, parallel-group, phase 3b trial

Bruce E. Sands, Peter M. Irving, Timothy Hoops et al. · The Lancet · 2022 · 277 citations

Immunology, Clinical Trials, Gastroenterology +7

A biomarker-stratified comparison of top-down versus accelerated step-up treatment strategies for patients with newly diagnosed Crohn's disease (PROFILE): a multicentre, open-label randomised controlled trial

Nurulamin M Noor, James Lee, Simon Bond et al. · ˜The œLancet. Gastroenterology & hepatology · 2024 · 229 citations · Full text

Clinical evidence for allergy in orofacial granulomatosis and inflammatory bowel disease

Pritash Patel, Jonathan Brostoff, Helen Campbell et al. · Clinical and Translational Allergy · 2013 · 43 citations · Full text

Thioguanine in inflammatory bowel disease: Long‐term efficacy and safety

Mark G. Ward, Kamal Patel, Viraj C. Kariyawasam et al. · United European Gastroenterology Journal · 2016 · 33 citations · Full text

Thiopurines Dosed to a Therapeutic 6-Thioguanine Level in Combination with Adalimumab Are More Effective Than Subtherapeutic Thiopurine-based Combination Therapy or Adalimumab Monotherapy During Induction and Maintenance in Patients with Long-standing Crohnʼs Disease

Viraj C. Kariyawasam, Mark G. Ward, Paul Blaker et al. · Inflammatory Bowel Diseases · 2017 · 23 citations · Full text